跳至主要内容
临床试验/CTRI/2018/02/011743
CTRI/2018/02/011743尚未招募2 期

Experimental and clinical studies on Nagapheni (Opuntia elatior Mill.), an anukta dravya (extra-pharmacopoeial drug), with special reference to its Haematinic activity

Ministry of AYUSH0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients between age of 18-70 years
  • 2.Patients of both gender
  • 3.Diagnosed cases of Pandu (iron deficiency anaemia)
  • 4.Patients having Hb% in between 8-10 g
  • 5.Patients with reduced RBC count

排除标准

  • 1.Age less than 18 years and more than 70 years.
  • 2.Pregnant women and lactating mothers.
  • 3.Cases of Chronic Renal (CRF)/
  • 4.Cases of Chronic Hepatic diseases, Cardiac diseases(CCF) and Cancer
  • 5.Any continuing blood loss e.g., Hematemesis, Melaena, Bleeding piles etc. having Hb% less than 7g%
  • 6.Patients consuming alcohol
  • 7.Patients those are on steroids treatment
  • 8.Patients with treatment of any haematinic drug(Ayurveda/modern) within last two months
  • 9.Minimum wash out period of two months if patients are under previous therapy.

研究者

相似试验